CLEVELAND — America is at war. But the war being discussed quite heavily — pardon the pun — in Cleveland this week is not the war on global terrorism but rather a war on obesity that should be declared, if it hasn't already, right here at home. (Medical Device Daily)

This year's Cleveland Clinic Medical Innovation Summit drew more than 1,000 attendees to the Cleveland Clinic campus and, according to Delos "Toby" Cosgrove, MD, president/CEO of the Cleveland Clinic, each of attendees has at least one thing in common: a concern about the quality of healthcare and the cost of healthcare. (Medical Device Daily)

As the 8th annual Cleveland Clinic Medical Innovation Summit kicks off today, speakers from top companies in the industry will take aim at the war on obesity. (Medical Device Daily)

It's no secret that these are tough times for orthopedic companies. But Stephen MacMillan, president/CEO and chairman of Stryker (Kalamazoo, Michigan) says the not-so-optimistic outlook for the orthopedic market – an area Stryker is known for – is "not at all" a reason the company has agreed to acquire the assets of the Neurovascular division of Boston Scientific (Natick, Massachusetts). (Medical Device Daily)

GE Healthcare (Chalfont St Giles, UK) said it has agreed to acquire Clarient (Aliso Viejo, California), a molecular diagnostics company, in a deal valued at $580 million. (Medical Device Daily)